RESUMEN
The influence of slaframine (SF), a parasympathomimetic compound isolated from the fungus Rizoctonia leguminicola, on circulating metabolic hormone concentrations was investigated in goats. In Exp. 1, SF was administered i.v. at 0 (CONT), 50 (LSF), 100 (MSF), or 150 (HSF) microgram/kg.75 BW in four mature Spanish-cross does (average BW 36 +/- 7 kg) fitted with indwelling jugular vein catheters in a 4 x 4 Latin square design. Plasma glucose peaked (P < .06) at 120 min with LSF and at 180 min with HSF and was higher (P <.06) than the CONT at these times. Glucose exhibited a quadratic response (P < .03) to SF. Area under the response curve for glucose differed (P < .02) in HSF from CONT and MSF. Insulin peaked (P < .01) at 240 min with MSF and at 180 min with HSF. Plasma triiodothyronine was maintained at a higher level (P < .03) with HSF. Thyroxine peaked (P < .06) at 120 min with MSF and 300 min with HSF. Plasma NEFA and somatotropin concentrations were not affected (P > .10) by SF. In Exp. 2, four mature Spanish-cross wethers (average BW 27 +/- 2 kg) fitted with jugular vein catheters were administered SF (0 and 114 micrograms/kg.75 BW) and 4-diphenylacetoxy-N-methylpiperidine methiodide (4DAMP; 0 and 258 micrograms/kg.75 BW), a M3-muscarinic receptor antagonist, i.v. in a 4 x 4 Latin square design with a 2 x 2 factorial arrangement of treatments. With SF, glucose peaked (P < .06) at 60 min and insulin peaked (P < .05) at 180 min. Plasma triiodothyronine levels were maintained (P < .05) with SF but declined with other treatments. Plasma NEFA and thyroxine concentrations remained unchanged regardless of treatment. Slaframine administration induced hyperglycemia and hyperinsulinemia in goats; however, these changes were blocked by preadministration of isomolar quantities of the M3-muscarinic receptor antagonist, 4DAMP.
Asunto(s)
Alcaloides/farmacología , Glándulas Endocrinas/fisiología , Cabras/fisiología , Agonistas Muscarínicos/farmacología , Antagonistas Muscarínicos/farmacología , Piperidinas/farmacología , Receptores Muscarínicos/fisiología , Alcaloides/administración & dosificación , Animales , Glucemia/análisis , Glándulas Endocrinas/efectos de los fármacos , Ácidos Grasos no Esterificados/sangre , Femenino , Enfermedades de las Cabras/sangre , Enfermedades de las Cabras/inducido químicamente , Cabras/sangre , Hormona del Crecimiento/sangre , Hiperglucemia/sangre , Hiperglucemia/inducido químicamente , Hiperglucemia/veterinaria , Hiperinsulinismo/sangre , Hiperinsulinismo/inducido químicamente , Hiperinsulinismo/veterinaria , Inyecciones Intravenosas/veterinaria , Insulina/sangre , Masculino , Agonistas Muscarínicos/administración & dosificación , Antagonistas Muscarínicos/administración & dosificación , Parasimpaticomiméticos/administración & dosificación , Parasimpaticomiméticos/farmacología , Piperidinas/administración & dosificación , Receptores Muscarínicos/efectos de los fármacos , Tiroxina/sangre , Triyodotironina/sangreRESUMEN
An experiment was conducted to determine if adding supplemental cholesterol to the feed or first adding it to the supplemental fat source of laying hen diets would result in differences in egg yolk and liver cholesterol levels. Five levels of cholesterol (0, .5, 1, 2, and 4%) and three levels of animal tallow (0, 4, and 8%) were used. The diets were randomly assigned and fed for 35 days to individually caged hens within each of six replicates. Eggs laid on or near Days 0, 7, 14, 21, 28, and 35 were used for cholesterol analysis. Liver cholesterol, egg production, and feed intake were also assessed. Mixing cholesterol with the fat source before feed incorporation did not promote higher yolk or liver cholesterol levels and were essentially the same as the method in which powdered cholesterol was added directly to the feed. A linear increase in yolk and liver cholesterol was observed with 0, .5, and 1% dietary cholesterol. Yolk cholesterol also increased linearly during the first 14 days of cholesterol administration. Further increases in yolk cholesterol, however, were not obtained with either the higher levels of dietary cholesterol or the extended feeding times.
Asunto(s)
Pollos/metabolismo , Colesterol en la Dieta/metabolismo , Colesterol/análisis , Yema de Huevo/análisis , Hígado/análisis , Animales , Colesterol/sangre , Colesterol en la Dieta/administración & dosificación , Ingestión de Alimentos , Femenino , Oviposición , Polvos , Distribución AleatoriaRESUMEN
Cinnamon and Brewer's yeast extracts have been shown to potentiate the action of insulin in isolated adipocytes. In this study, isolated rat epididymal adipocytes were used to evaluate the influence of bovine serum albumin on insulin activity as affected by cinnamon and Brewer's yeast extracts. Albumin at 0.01-0.1% decreased the insulin stimulatory effects of cinnamon from 11.8- to 5.3-fold and 2% albumin decreased this effect to near control levels. Conversely, the insulin-enhancing properties of Brewer's yeast remained low in the presence of less than 0.25% albumin but subsequently increased 2.8-, 4.8- and 5.6-fold in the presence of 0.25, 0.50 and 1.0% albumin, respectively. In the absence of added insulin, increased activity of the insulin-stimulated utilization of glucose by both extracts was observed but only Brewer's yeast extract displayed additive effects when tested at higher insulin levels. Due to the inhibitory and enhancing effects of albumin on the insulin activity of cinnamon and Brewer's yeast, respectively, it is suggested that the effects of albumin be assessed when evaluating the insulin-enhancing effects of other substances using isolated adipocytes.